Mynd_Logo_2.png
MENU
mynd-menu.png
Mynd Life Sciences
  • Feb 2, 2021

MYND Life Sciences Inc. Announces Collaborative Research Agreement with the University of British Co

VANCOUVER, BC, Feb. 2, 2021 /PRNewswire/ – MYND Life Sciences Inc. (“MYND“) a life sciences company focused on novel psychedelic drug...
Mynd Life Sciences
  • Feb 1, 2021

MYND Life Sciences CEO Invited to Present at Canaccord Genuity’s New Paradigms and Treatment A

VANCOUVER, BC, Feb. 1, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND“) a life sciences company focused on novel psychedelic drug...
Mynd Life Sciences
  • Jan 7, 2021

MYND Life Sciences Inc. Closes $2.4 Million Private Placement and Provides Update on Planned Listing

VANCOUVER, BC, Jan. 7, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND“) a life sciences company focused on novel psychedelic drug...
6789
10
6243633205_d7126ef00c_o_edited.jpg
MYND-FUTURE.png
DIAGNOSTICS
INVESTING
SCIENCE
 
CONTACT
NEWS
  • Twitter
  • Instagram
  • LinkedIn
  • Facebook

© Copyright Mynd Life Sciences 2022

Privacy